Detection Of Tcd4+ Subsets In Human Carotid Atheroma

Activated TCD4+ cells are detected in human atherosclerotic plaques which indicate their participation in disease progression and destabilization. Among these cells, IFN-γ-producing T cells (TH1) are recognized as having a pro-atherogenic role. Recently, the IL-17-producing T helper lineage of cells (TH17) has been identified in atherosclerotic lesions. They have been linked to atheroma development through the production of pro-inflammatory mediators present in these lesions. Furthermore, IL-22 producing TCD4+ cells (TH22) have been identified in the atheromatous environment, but their presence and function has not been investigated. The aim of this study was to analyze the immune response mediated by pro-inflammatory subtypes of TCD4+ cells in atheromatous lesions. Atherosclerotic plaques of 57 patients with critical stenosis of carotid submitted to endarterectomy were evaluated. Three carotid fragments from organ donors were used as control. mRNA analysis showed expression of TH1 (IFN-γ, T-bet, IL-2, IL-12p35, TNF-α and IL-18); TH2 (GATA-3); TH17 (IL-17A, IL-17RA, Rorγt, TGF-β, IL-6, IL-1β, IL-23p19, CCL20, CCR4 and CCR6) and TH22 (IL-22 and Ahr) related markers. Asymptomatic patients showed higher expression of mRNA of IL-10, TGF-β, CCR4 and GATA-3 when compared to symptomatic ones. Immunohistochemistry analysis showed higher levels of IL-23, TGF-β, IL-1β and IL-18 in macrophages and foam cells in unstable lesions compared to stable and control ones. In vitro stimulation of atheroma cells induced IL-17 and IFN-γ production. Finally we were able to detect, the following subpopulations of TCD3+ cells: TCD4+ IFN-γ+, TCD4+IL-17+, TCD4+IL-4+, TCD4+IL-22+ and double positive cells (IFN-γ/IL-17+, IFN-γ/IL-22+ or IL-17/IL-22+). Our results showed the presence of distinct TCD4+ cells subsets in human carotid lesions and suggest that interactions among them may contribute to the atheroma progression and destabilization. © 2013 Elsevier Ltd.621131140Steinberg, D., Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime (2002) Nat Med, 8, pp. 1211-1217Hansson, G.K., Hermansson, A., The immune system in atherosclerosis (2011) Nat Immunol, 12, pp. 204-212Zhou, X., Nicoletti, A., Elhage, R., Hansson, G.K., Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice (2000) Circulation, 102, pp. 2919-2922Uyemura, K., Demer, L.L., Castle, S.C., Jullien, D., Berliner, J.A., Gately, M.K., Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis (1996) J Clin Invest, 97, pp. 2130-2138Gerdes, N., Sukhova, G.K., Libby, P., Reynolds, R.S., Young, J.L., Schonbeck, U., Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis (2002) J Exp Med, 195, pp. 245-257Zhu, J., Yamane, H., Paul, W.E., Differentiation of effector CD4 T cell populations (*) (2010) Annu Rev Immunol, 28, pp. 445-489Buono, C., Come, C.E., Stavrakis, G., Maguire, G.F., Connelly, P.W., Lichtman, A.H., Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse (2003) Arterioscler Thromb Vasc Biol, 23, pp. 454-460Gupta, S., Pablo, A.M., Jiang, X., Wang, N., Tall, A.R., Schindler, C., IFN-gamma potentiates atherosclerosis in ApoE knock-out mice (1997) J Clin Invest, 99, pp. 2752-2761Andersson, J., Libby, P., Hansson, G.K., Adaptive immunity and atherosclerosis (2010) Clin Immunol, 134, pp. 33-46Davenport, P., Tipping, P.G., The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice (2003) Am J Pathol, 163, pp. 1117-1125Huber, S.A., Sakkinen, P., David, C., Newell, M.K., Tracy, R.P., T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia (2001) Circulation, 103, pp. 2610-2616Lahoute, C., Herbin, O., Mallat, Z., Tedgui, A., Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets (2011) Nat Rev Cardiol, 8, pp. 348-358Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M., Stockinger, B., TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells (2006) Immunity, 24, pp. 179-189Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jager, A., Strom, T.B., IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells (2007) Nature, 448, pp. 484-487Stritesky, G.L., Yeh, N., Kaplan, M.H., IL-23 promotes maintenance but not commitment to the Th17 lineage (2008) J Immunol, 181, pp. 5948-5955Acosta-Rodriguez, E.V., Napolitani, G., Lanzavecchia, A., Sallusto, F., Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells (2007) Nat Immunol, 8, pp. 942-949Ivanov, I.I., McKenzie, B.S., Zhou, L., Tadokoro, C.E., Lepelley, A., Lafaille, J.J., The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells (2006) Cell, 126, pp. 1121-1133Acosta-Rodriguez, E.V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells (2007) Nat Immunol, 8, pp. 639-646Eid, R.E., Rao, D.A., Zhou, J., Lo, S.F., Ranjbaran, H., Gallo, A., Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells (2009) Circulation, 119, pp. 1424-1432Taleb, S., Romain, M., Ramkhelawon, B., Uyttenhove, C., Pasterkamp, G., Herbin, O., Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis (2009) J Exp Med, 206, pp. 2067-2077Cheng, X., Taleb, S., Wang, J., Tang, T.T., Chen, J., Gao, X.L., Inhibition of IL-17A in atherosclerosis (2011) Atherosclerosis, 215, pp. 471-474Eyerich, S., Eyerich, K., Pennino, D., Carbone, T., Nasorri, F., Pallotta, S., Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling (2009) J Clin Invest, 119, pp. 3573-3585Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A., Sallusto, F., Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells (2009) Nat Immunol, 10, pp. 857-863Trifari, S., Kaplan, C.D., Tran, E.H., Crellin, N.K., Spits, H., Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells (2009) Nat Immunol, 10, pp. 864-871Witte, E., Witte, K., Warszawska, K., Sabat, R., Wolk, K., Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection (2010) Cytokine Growth Factor Rev, 21, pp. 365-379Xia, Q., Xiang, X., Patel, S., Puranik, R., Xie, Q., Bao, S., Characterisation of IL-22 and interferon-gamma-inducible chemokines in human carotid plaque (2012) Int J Cardiol, 154, pp. 187-189Pfaffl, M.W., A new mathematical model for relative quantification in real-time RT-PCR (2001) Nucleic Acids Res, 29, pp. e45Verhoeven, B.A.N., Velema, E., Schoneveld, A.H., de Vries, J.P.P.M., Bruin, P., Seldenrijk, C.A., Athero-express: differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design (2004) European Journal of Epidemiology, 19, pp. 1127-1133Frostegard, J., Ulfgren, A.K., Nyberg, P., Hedin, U., Swedenborg, J., Andersson, U., Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines (1999) Atherosclerosis, 145, pp. 33-43Harvey, E.J., Ramji, D.P., Interferon-gamma and atherosclerosis: pro- or anti-atherogenic? (2005) Cardiovasc Res, 67, pp. 11-20Leon, M.L., Zuckerman, S.H., Gamma interferon: a central mediator in atherosclerosis (2005) Inflamm Res, 54, pp. 395-411Amento, E.P., Ehsani, N., Palmer, H., Libby, P., Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells (1991) Arterioscler Thromb, 11, pp. 1223-1230Hansson, G.K., Hellstrand, M., Rymo, L., Rubbia, L., Gabbiani, G., Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells (1989) J Exp Med, 170, pp. 1595-1608McLaren, J.E., Ramji, D.P., Interferon gamma: a master regulator of atherosclerosis (2009) Cytokine Growth Factor Rev, 20, pp. 125-135Walch, L., Massade, L., Dufilho, M., Brunet, A., Rendu, F., Pro-atherogenic effect of interleukin-4 in endothelial cells: modulation of oxidative stress, nitric oxide and monocyte chemoattractant protein-1 expression (2006) Atherosclerosis, 187, pp. 285-291Sampi, M., Ukkola, O., Paivansalo, M., Kesaniemi, Y.A., Binder, C.J., Horkko, S., Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis (2008) J Am Coll Cardiol, 52, pp. 1370-1378Amadi-Obi, A., Yu, C.R., Liu, X., Mahdi, R.M., Clarke, G.L., Nussenblatt, R.B., TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1 (2007) Nat Med, 13, pp. 711-718Wilson, N.J., Boniface, K., Chan, J.R., McKenzie, B.S., Blumenschein, W.M., Mattson, J.D., Development: cytokine profile and function of human interleukin 17-producing helper T cells (2007) Nat Immunol, 8, pp. 950-957Yang, L., Anderson, D.E., Baecher-Allan, C., Hastings, W.D., Bettelli, E., Oukka, M., IL-21 and TGF-beta are required for differentiation of human T(H)17 cells (2008) Nature, 454, pp. 350-352Erbel, C., Dengler, T.J., Wangler, S., Lasitschka, F., Bea, F., Wambsganss, N., Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability (2011) Basic Res Cardiol, 106, pp. 125-134Zhu, F., Wang, Q., Guo, C., Wang, X., Cao, X., Shi, Y., IL-17 induces apoptosis of vascular endothelial cells - A potential mechanism for human acute coronary syndrome (2011) Clin ImmunolPark, H., Li, Z., Yang, X.O., Chang, S.H., Nurieva, R., Wang, Y.H., A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 (2005) Nat Immunol, 6, pp. 1133-1141Fujita, H., Nograles, K.E., Kikuchi, T., Gonzalez, J., Carucci, J.A., Krueger, J.G., Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production (2009) Proc Natl Acad Sci USA, 106, pp. 21795-21800Liang, S.C., Nickerson-Nutter, C., Pittman, D.D., Carrier, Y., Goodwin, D.G., Shields, K.M., IL-22 induces an acute-phase response (2010) J Immunol, 185, pp. 5531-5538Yu, K., Chen, Z., Khatri, I., Gorczynski, R.M., CCR4 dependent migration of Foxp3+ Treg cells to skin grafts and draining lymph nodes is implicated in enhanced graft survival in CD200tg recipients (2012) Immunol Lett, 141, pp. 116-122Oppmann, B., Lesley, R., Blom, B., Timans, J.C., Xu, Y., Hunte, B., Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 (2000) Immunity, 13, pp. 715-725Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R (2002) J Immunol, 168, pp. 5699-5708McGeachy, M.J., Chen, Y., Tato, C.M., Laurence, A., Joyce-Shaikh, B., Blumenschein, W.M., The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo (2009) Nat Immunol, 10, pp. 314-324Ahern, P.P., Schiering, C., Buonocore, S., McGeachy, M.J., Cua, D.J., Maloy, K.J., Interleukin-23 drives intestinal inflammation through direct activity on T cells (2010) Immunity, 33, pp. 279-288Gerosa, F., Baldani-Guerra, B., Lyakh, L.A., Batoni, G., Esin, S., Winkler-Pickett, R.T., Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells (2008) J Exp Med, 205, pp. 1447-1461Patel, S., Chung, S.H., White, G., Bao, S., Celermajer, D.S., The "atheroprotective" mediators apolipoproteinA-I and Foxp3 are over-abundant in unstable carotid plaques (2009) Int J CardiolAit-Oufella, H., Salomon, B.L., Potteaux, S., Robertson, A.K., Gourdy, P., Zoll, J., Natural regulatory T cells control the development of atherosclerosis in mice (2006) Nat Med, 12, pp. 178-180Pinderski Oslund, L.J., Hedrick, C.C., Olvera, T., Hagenbaugh, A., Territo, M., Berliner, J.A., Interleukin-10 blocks atherosclerotic events in vitro and in vivo (1999) Arterioscler Thromb Vasc Biol, 19, pp. 2847-2853Robertson, A.K., Rudling, M., Zhou, X., Gorelik, L., Flavell, R.A., Hansson, G.K., Disruption of TGF-beta signaling in T cells accelerates atherosclerosis (2003) J Clin Invest, 112, pp. 1342-135